DBD DIEBOLD NIXDORF, Inc
Calculating & Accounting Machines (No Electronic Computers) · NYSE · SEC CIK 28823 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.3%
TTM net income YoY51.6%
TTM EPS YoY56.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin25.0%
Operating margin5.4%
Net margin2.0%
FCF margin—
EBITDA margin7.3%
Returns
ROE7.5%
ROA2.1%
ROIC (approx.)8.1%
Asset turnover1.06x
Leverage & solvency
Liabilities / assets74.2%
Debt / equity1.01x
Current ratio1.27x
Interest coverage2.23x
Cash quality & payout
Operating cash flow / net income2.45x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $3.81B | $3.75B |
| Cost of revenue | $2.84B | $2.83B |
| Gross profit | $961.20M | $920.00M |
| R&D expense | $86.70M | $93.60M |
| SG&A expense | $632.50M | $643.60M |
| Operating income | $242.00M | $182.10M |
| Interest expense | $85.70M | $155.30M |
| Pretax income | $125.10M | $47.30M |
| Income tax | $24.10M | $64.30M |
| Net income | $94.60M | -$16.50M |
| EBITDA | $369.50M | $314.40M |
| EPS (basic) | 2.57 | -0.44 |
| EPS (diluted) | 2.54 | -0.44 |
| Weighted avg. shares (diluted) | 37.20M | 37.60M |
| Balance sheet | ||
| Cash & equivalents | $387.30M | $311.30M |
| Short-term investments | $29.10M | $16.90M |
| Receivables | $609.40M | $588.50M |
| Inventory | $521.00M | $528.10M |
| Current assets | $1.79B | $1.67B |
| PP&E, net | — | $128.10M |
| Goodwill | $642.40M | $586.40M |
| Intangibles | $792.40M | $778.60M |
| Total assets | $3.85B | $3.54B |
| Current liabilities | $1.37B | $1.27B |
| Short-term debt | — | $200,000 |
| Long-term debt | $938.50M | $927.30M |
| Total debt | $938.50M | $927.50M |
| Total liabilities | $2.75B | $2.61B |
| Shareholders' equity | $1.10B | $929.80M |
| Net debt | $551.20M | $616.20M |
| Shares outstanding | 35.38M | 37.58M |
| Cash flow statement | ||
| Operating cash flow | $300.70M | $149.20M |
| Investing cash flow | -$97.60M | -$45.50M |
| Financing cash flow | -$143.90M | -$366.50M |
| Depreciation & amortization | $127.50M | $132.30M |
| Stock-based compensation | $12.10M | $9.70M |
| Share buybacks | $130.70M | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.